News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
24/7 Wall St.89d agobullish
Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles ConsensusMotley Fool112d agobullish
Is It Too Late to Buy Johnson & Johnson After Its Blowout Earnings Report?InvestorsHub116d agobullish
Johnson & Johnson tops second-quarter forecasts and lifts guidance despite premarket decline (JNJ)Reuters116d agobullish
J&J quarterly earnings beat Wall Street estimates on strength of medicines unitInvestor's Business Daily125d agobullish
Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings